EPHB2, EPH receptor B2, 2048

N. diseases: 649; N. variants: 19
Source: ALL
Disease Type Disease Class Semantic Type N. genes d N. SNPs d Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
phenotype Neoplastic Process 6626 169 0.100 None 1.000 148 1 2002 2020
Malignant neoplasm of colon and/or rectum
disease Neoplastic Process 3669 502 0.100 None 1.000 34 2 2001 2019
CUI: C4525297
Disease: Stage 0 Gallbladder Cancer AJCC v8
Stage 0 Gallbladder Cancer AJCC v8
disease Neoplastic Process 367 56 0.050 None 1.000 5 2015 2019
Stage IIA Gallbladder Cancer AJCC v8
disease Neoplastic Process 367 56 0.050 None 1.000 5 2015 2019
Stage IIB Gallbladder Cancer AJCC v8
disease Neoplastic Process 367 56 0.050 None 1.000 5 2015 2019
Stage III Gallbladder Cancer AJCC v8
disease Neoplastic Process 367 56 0.050 None 1.000 5 2015 2019
CUI: C4525305
Disease: Stage IV Gallbladder Cancer AJCC v8
Stage IV Gallbladder Cancer AJCC v8
disease Neoplastic Process 367 56 0.050 None 1.000 5 2015 2019
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
disease Disease or Syndrome 593 24 0.040 None 1.000 4 2005 2017
CUI: C0236734
Disease: Caffeine related disorders
Caffeine related disorders
group Mental or Behavioral Dysfunction 360 56 0.020 None 1.000 2 2013 2018
CUI: C0346360
Disease: Malignant melanoma of conjunctiva
Malignant melanoma of conjunctiva
disease Neoplastic Process 30 2 0.020 None 1.000 2 2015 2019
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
disease Disease or Syndrome 467 14 0.020 None 1.000 2 2005 2019
CUI: C1611743
Disease: Familial (FPAH)
Familial (FPAH)
disease Disease or Syndrome 1075 276 0.020 None 1.000 2 2008 2011
androgen independent prostate cancer
disease Neoplastic Process 190 5 0.020 None 1.000 2 2011 2016
Central Nervous System Sensitization
disease Disease or Syndrome 32 1 0.020 None 1.000 2 2017 2018
Oestrogen receptor positive breast cancer
disease Neoplastic Process 510 58 0.020 None 0.500 2 2014 2015
CUI: C2985280
Disease: Blood Protein Measurement
Blood Protein Measurement
phenotype Laboratory Procedure 1156 2575 0.100 None 1.000 2 4 2018 2018
CUI: C3714948
Disease: PACHYONYCHIA CONGENITA 3
PACHYONYCHIA CONGENITA 3
disease Disease or Syndrome 209 20 0.020 None 1.000 2 2006 2007
CUI: C0028259
Disease: Nodule
Nodule
phenotype Acquired Abnormality 278 19 0.010 None 1.000 1 2018 2018
CUI: C0202231
Disease: Thyroxine measurement
Thyroxine measurement
phenotype Laboratory Procedure 24 42 0.100 None 1.000 1 1 2019 2019
CUI: C0221106
Disease: Alkalemia
Alkalemia
disease Disease or Syndrome 38 0.010 None 1.000 1 2014 2014
CUI: C0238790
Disease: bone destruction
bone destruction
disease Disease or Syndrome 234 3 0.010 None 1.000 1 2017 2017
CUI: C0272401
Disease: Virchow's node (disorder)
Virchow's node (disorder)
disease Sign or Symptom 30 1 0.010 None 1.000 1 2014 2014
CUI: C0278678
Disease: Metastatic Renal Cell Cancer
Metastatic Renal Cell Cancer
disease Neoplastic Process 145 9 0.010 None 1.000 1 2015 2015
Squamous cell carcinoma of the hypopharynx
disease Neoplastic Process 103 3 0.010 None 1.000 1 2019 2019
CUI: C0334037
Disease: Intestinal metaplasia
Intestinal metaplasia
phenotype Disease or Syndrome 266 24 0.010 None 1.000 1 2008 2008